PRASCO, LLC

PRASCO, LLC specializes in the manufacturing of pharmaceutical preparations and medicinal botanical products for federal health and defense agencies. The company delivers end-to-end production of active pharmaceutical ingredients and finished dosage forms, including topical creams, antiparasitic formulations, and specialized hematology-related therapeutics. Their technical expertise encompasses cGMP-compliant manufacturing processes, sterile and non-sterile compounding, and supply chain integrity for controlled substance handling. PRASCO demonstrates deep proficiency in meeting stringent FDA and DoD quality standards, with demonstrated experience in producing complex formulations such as atovaquone-proguanil and calcipotriene cream under tight regulatory oversight. Their ability to scale production for mission-critical medical needs while maintaining batch consistency and documentation integrity sets them apart in the federal supply ecosystem. The contractor maintains a consistent presence with the Department of Defense, Department of Veterans Affairs, and Department of Health and Human Services, delivering mission-critical pharmaceuticals for military readiness, veteran healthcare, and public health programs. Their work with DoD focuses on battlefield-ready therapeutics and medical countermeasures, while VA engagements center on chronic condition management and long-term care formulations. HHS contracts reflect support for national pharmaceutical stockpiling and emergency response needs. PRASCO’s industry focus is anchored in NAICS 325412 (Pharmaceutical Preparation Manufacturing) and 325411 (Medicinal and Botanical Manufacturing), positioning them as a niche supplier of specialty therapeutics and plant-derived pharmaceuticals. They serve the federal biopharmaceutical market with precision manufacturing of low-volume, high-complexity products often excluded from commercial supply chains. As a small business structured as a 2L entity based in Mason, Ohio, PRASCO operates with agility and regulatory discipline. Though currently without formal government certifications, their consistent performance with high-sensitivity agencies underscores a reliable track record in compliant, mission-aligned pharmaceutical production.